Venetoclax for older patients with AML? 'Remarkable' response
from Medscape (free login required)
Elderly patients with acute myeloid leukemia (AML) urgently need effective treatment options. Hope may be on the horizon for these patients after results from an early-phase trial showed "remarkable" results with a combination of venetoclax (Venclexta, AbbVie/Genentech) and hypomethylating agents (decitabine or azacitidine).
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063